Library - Page 5 - Scientific articles and publications about the drug Mexidol®.

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Pharmacology of antioxidants based on 3-oxypyridine

Authors:
NOVIKOV V.E., KOVALEVA L.A., LOSENKOVA S.O., KLIMKINA E.I.

Smolensk State Medical Academy

Treatment of alcohol cancellation syndrome

Author:
SIVOLAP Yu.P.

FGBAOU VO "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia

The possibility of using Mexidol in the complex therapy of mental disorders

Authors:
SHAMREY V.K., KURASOV E.S., NECHIPORENKO V.V., KOLCHEV A.I., TSYGAN N.V.

FGBVOU in the "Military Medical Academy named after CM. Kirov ”, St. Petersburg, Russia

The dynamics of electroenzelographic and psychophysiological indicators in acute poisoning by neurotoxicants at the rehabilitation stage against the background of various treatment methods

Authors:

BADALYAN A.V., BEREZINA I.Yu., GOLDFARB Yu.S., SUMSKY L.I.

Place of publication:

Journal of Neurology and Psychiatry, 2, 2017

The influence of Mexidol in combination with therapy with antidepressants on sleep disturbance with panic disorder in young people

Authors:
KURASOV E.S. , REMIZEVICH R.S.

Military Medical Academy. CM. Kirova, St. Petersburg

Comparative assessment of the effectiveness of standard therapy and combination of Mexidol with convulsan at the stage of early rehabilitation of patients with opium drug addiction

Authors:
MELNIKOV M.A., KARPOV A.M.

Republican Narcological Dispensary of the Ministry of Health of the Republic of Tatarstan;
Kazan State Medical Academy

The effectiveness of the use of Mexidol with convulsive syndrome of withdrawal and post -traumatic genesis

Author:
V.A. BREDELEV

Arkhangelsk Regional Clinical Psychiatric Hospital

Application of Mexidol in Urgenic Narcology

Authors:
KLINDUKHOVA O.I., NOVGORODOV O.E., SERGIENKO N.N., DANILYUK P.V., BELOTSERKOVICH O.V.

Regional narcological dispensary, Krasnoyarsk

Therapeutic efficiency of Mexidol, when stopping various options for alcohol withdrawal syndrome

Authors:

Kashichkina O.V., Krieger N.A.

Saratov Regional Psychiatric Hospital of St. Sophia

Mexidol in the complex therapy of post -traumatic stress disorders

Authors:
S.A. TsAREGORODTSEVA, M.YU. BONDARENKO, VAKHRANEVA E.V., AZIN A.L.

Republican Clinical Hospital for War Veterans;
Center for Medical, Psychological, and Social Rehabilitation of Veterans of Combat and Counter-Terrorism Operations and Their Families, Yoshkar-Ola

The experience of using the drug "Mexidol" in the structure of pharmacotherapy of various clinical forms of neurosis

Author:
ALESHINA N.V.

Departure of the crisis conditions of the Saratov city neuropsychiatric dispensary

The influence of Mexidol on the improvement of cognitive status and quality parameters as part of the complex therapy of patients with chronic heart failure of the II - III functional class

Author:
TOLKACHEVA V.V., KARAPETYAN L.V., KHUTSISHVILI N.I., GALOCHKIN S.A., KAZAKHMEDOV E.R., KOBALAVA Zh.D.

FGAOU in Russian University of Friendship of Peoples named after Patrice Lumumba, Moscow, Russia

Cognitive disorders in patients with a cardiological profile: diagnosis and prevention

Author:
E.K. SHAVAROVA^1,2, A.A. SHAVAROV¹, R.E. AKHMETOV³, J.D. KOBALAVA^1,2

¹Peoples' Friendship University of Russia, Moscow, Russia;
²Vinogradov City Clinical Hospital, Moscow, Russia;
³PHARMASOFT Research and Production Company, Moscow, Russia

The relationship of cardiovascular diseases and cerebrovascular complications

Authors:

Ostroumova T.M., Kochetkov A.I.

Place of publication:

11,2022

Mexidol effects in patients with chemical and heart failure II - III functional class

Authors:
A.V. SHCHULKIN², E.R. KAZAKHMEDOV¹, S.A. GALOCHKIN¹, V.V. TOLKACHEVA¹, J.D. KOBALAVA¹

¹Peoples' Friendship University of Russia, Moscow;
²Ryazan State Medical University named after Academician I.P. Pavlov of the Ministry of Health of the Russian Federation, Ryazan

Cognitive disorders for heart failure: the role of microcirculation disorders

Authors:

Chimagomedova A.Sh., Gioeva Z.R., Akhilgova Z.M., Kurkina M.V., Avtandilov A.G.

FSBEI DPO Russian Medical Academy of Continuing Professional Education, Moscow, Russia

Place of publication:

S.S. Korsakov Journal of Neurology and Psychiatry
2020, Vol. 120, No. 10, Issue 2

« 1 … 3 4 5 6 7 … 14 »